Loss Aversion and Cost Effectiveness of Healthcare Programmes: Whose Aversion Counts Anyway?

The article comments on "Loss Aversion and Cost Effectiveness of Healthcare Programmes," by Afschin Gandjour which is in this issue of "PharmacoEconomics." The author's opinion is that Gandjuor's method for incorporating loss aversion into cost-effectiveness estimates for health initiatives is too simple because it does not apply a population-based incremental cost-effectiveness ratio.